Clinical trial Recruiting at 1 site Interventional Ages 40 to 85

Thoracic epidural spinal cord stimulation to reduce freezing of gait in advanced Parkinson's disease

Official title: Application of Thoracic Epidural Spinal Cord Stimulation (SCS) for Managing Freezing of Gait (FOG) in Patients With Advanced Parkinson's Disease

Run by National Taiwan University Hospital · NCT06630702 · Data updated 2026-11-12

This study will try temporary thoracic spinal cord stimulation to see if it helps people with advanced Parkinson's disease whose freezing of gait does not respond to medications.

More Parkinson Disease trials

Quick facts

Study typeInterventional
Ages40 Years to 85 Years
SexAll
Enrollment5 (estimated)
SponsorNational Taiwan University Hospital
Academic / other
Locations1 site (Hsinchu, Hsinchu City)
StatusRecruiting
StartedSeptember 20, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedNovember 20, 2025
Trial IDNCT06630702 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 40–85-year-old patients with primary Parkinson's disease of more than five years who have freezing of gait that does not respond to medications and no secondary gait problems or spinal conditions that would block electrode placement.

Probably not a fit

Patients with atypical Parkinsonism, medication-controlled freezing of gait, spinal cord injuries, significant spinal stenosis or myelopathy at the implantation site, prior surgery or infection near the target area, or other major comorbidities are unlikely to benefit or may be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Investigators will place temporary, minimally invasive thoracic epidural stimulation electrodes and test different stimulation settings to see if gait stability and freezing episodes improve. The trial enrolls people aged 40–85 with primary Parkinson's disease for more than five years who have medication-refractory freezing of gait and no other secondary gait disorders. Outcomes will include measures of gait, freezing frequency, fall risk, and safety during and after temporary stimulation. The procedures are performed at a single center (National Taiwan University Hospital Hsin-Chu Branch) with exclusions for spinal canal stenosis, prior surgery or infection near the implantation site, atypical Parkinsonism, and spinal cord injury.

Why it matters

Potential benefit: If successful, temporary thoracic epidural SCS could improve walking stability and reduce falls in people with medication-refractory freezing of gait.

How similar studies have gone: Small case series and preliminary reports have shown gait and symptom improvements after spinal cord stimulation in Parkinson's patients, but the approach remains experimental and not yet widely validated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age:40-85 years old.
* Patients with primary Parkinson\'s disease who have been diagnosed by a movement disorder specialist for more than 5 years. Although they have a clear response to drugs, they have a frozen gait that cannot be controlled by drugs. Lower limb pain may be present with or without Parkinson\'s non-motor symptoms.
* No other secondary gait problems.

Exclusion Criteria:

* Atypical Parkinson's disease.
* Patients with spinal cord injuries.
* Medication-controlled frozen gait.
* It is expected that there are lesions near the implantation area causing spinal canal stenosis or myelopathy (can be ruled out by MRI).
* It is expected that the implantation area has undergone previous surgery or there is infection near the implantation area, which may affect the success rate of implantation or increase concerns about complications (such as severe extraspinal adhesion, or spinal cord damage in previous surgeries).
* People with abnormal coagulation function (such as hemophilia patients) or those who have been controlled by long-term use of antithrombotic drugs and cannot stop taking them in a short period of time.
* CDR (Clinical Dementia Rating Scale) ≧2. 8. Those who are allergic to developer.

Where it's running

  • National Taiwan University Hospital Hsin-Chu Branch
    Hsinchu, Hsinchu City, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.